TACT study of chelation therapy again in spotlight
The $30 million TACT trial, sponsored by the National Center for Complementary and Alternative Medicine (NCCAM) and the National Institutes of Health, was stopped in 2008 while "allegations of impropriety" were investigated. These centered on concerns …
See all stories on this topic »